Futures rally as earnings season rolls on 📈

Good Morning! Hey, there! It's Chris from Elite Trade Club, here to give you this morning's premarket trading news. Today is Thursday, July 27th. I hope you have a great day in the market. Let's get ready to trade! Markets 📈 The Dow closed with a 0.2% gain on Wednesday, extending its win streak to 13 sessions. The S&P 500 ended the session with a thin loss of less than 0.1%, while the Nasdaq lost a full 0.1%. The small-cap Russell 2K outperformed with a 0.7% gain. Futures are on the rise thanks to a strong earnings report from Meta [META] in Wednesday's after market. S&P 500 contracts are up by about 0.5%. Sponsored [A 100% Win Rate In 2022?]( 🏆 This reclusive investor hasn't closed a single losing trade since 2016... Sounds impossible? It's not - and he'll prove it to you. Plus, he shares his number one recommendation for beating the market in 2023. [See His Top Picks Here]( Premarket Highlights 🔎 📈 Meta Earnings Fuel Nasdaq Rally Facebook parent Meta reported its highest quarterly sales growth since 2021 in its Q2 earnings report after Wednesday's closing bell. The strong sales growth was largely due to a significant rebound in digital ad spend. However, Meta cautioned that it expects spending to soar in 2024 as it pushed to grow its experimental metaverse unit. What to Watch Today 👀 Big Day for Earnings Earnings season continues on Thursday, with big reports from Mastercard, Comcast, Intel, and others. Markets appear to be feeling optimistic after the Fed's rate hike, even though Chairman Powell signaled the possibility of at least one more hike before the end of the year. If companies continue to deliver encouraging results on earnings, we could see the momentum lift stocks even higher in the coming days & weeks. Major Earnings 💰 MasterCard Incorporated [MA] ... AM AbbVie Inc. [ABBV] ... AM McDonald's Corporation [MCD] ... AM Linde Plc [LIN] ... AM Comcast Corporation [CMCSA] ... AM Honeywell International Inc. [HON] ... AM S&P Global Inc. [SPGI] ... AM Bristol-Myers Squibb Company [BMY] ... AM T-Mobile Us, Inc. [TMUS] ... PM Intel Corporation [INTC] ... PM Economy 🏗 - Initial jobless claims [Jul] ... 8:30a - Durable-goods orders [Jun] ... 8:30a - GDP (advanced report) [Q2] ... 8:30a - Advanced U.S. trade balance in goods [Jun] ... 8:30a - Advanced retail inventories [Jun] ... 8:30a - Advanced wholesale inventories [Jun] ... 8:30a - Pending home sales [Jun] ... 10:00a Running Hot 🔥 Gainers - Mallinckrodt PLC [MNK] >> +28.5% - Nextracker [NXT] >> +20.0% - Titan Pharma [TTNP] >> +16.2% - Ultralife [ULBI] >> +28.6% Decliners - Mersana Therapeutics [MRSN] >> (73.3%) - Yellow Corp [YELL] >> (24.5%) - National Vision [EYE] >> (22.1%) - TPI Composites [TPIC] >> (18.2%) Align Technology [ALGN] - Last Close: $339.85 Align is getting a boost after releasing its latest quarterly results. The orthodontics company reported its Q2 report following Wednesday's close, and it surpassed analysts' expectations. Align generated EPS of $2.22 on revenues of $1 billion, beating the consensus of $2.04 EPS on $990.8 million in revenues. The company's Q3 and fiscal 2023 guidance also surpassed the Street's expectations. ALGN is leading the S&P 500 with a 15.7% gain. My Take: ALGN got punished during the 2022 sell off, but it's starting to get its groove back. This stock was trading for upwards of $700 a couple of years ago, so it could have huge upside if it can maintain its positive trend. Celestica [CLS] - Last Close: $16.46 Strong earnings are lifting shares of Celestica in today's premarket. The electronic equipment company reported its Q2 earnings after Wednesday's closing bell, and the results surpassed analysts' expectations. Celestica reported EPS of $0.55 on sales of $1.94 billion; easily topping the consensus of $0.47 on $1.82 billion in sales. The company also boosted its full-year outlook on the news, and its new guidance also outperformed expectations. CLS is one of the top performers in today's premarket with a 30.3% gain. My Take: CLS has been on a hot run lately, but it was beginning to encounter some resistance around $16.50. Today's rally could be the final push it needs to get over the hump. Carmel Therapeutics [CTCX] - Last Close: $3.00 A merger deal is boosting shares of Carmel Therapeutics. This morning, the company announced a definitive merger agreement with privately-held Axolotl Biologix. Under the terms of the deal, CTCX shareholders will receive $8 million cash and $57 million worth of CTCX stock on closing. The deal also includes up to $75 million in potential "milestone equity payments" structured as 12% cash and 88% CTCX stock. CTCX is today's top premarket stock with a 46.9% gain, and it's one of this morning's most-traded stocks. My Take: I don't know much about Axolotl, but the market seems to think CTCX landed one helluva deal here. However, the stock had been getting killed prior to this announcement, so be wary of a pullback once this momentum fades. Lipocine [LPCN] - Last Close: $4.30 Lipocine just announced a promising clinical update from a key drug trial. The biopharma firm said a Phase 2 study of LPCN 1148 for the clinical management of cirrhosis met its primary endpoint. LPCN 1148 produced substantial symptom improvements compared to placebo and was well tolerated among patients. Lipocine said it plans to meet with the FDA to discuss a development path to filing a New Drug Application for the drug's approval. LPCN is up 37.4% on elevated trading volume in response to the upbeat clinical data. My Take: This is some much-needed good news for LPCN. It sounds like LPCN 1148 could be on the track to a full approval, which could deliver another catalyst down the road. That's it for today! Thanks for reading, and good luck out there! Best Regards, Chris D. -- Elite Trade Club P.S... Want alerts delivered straight to your cell every morning for free?* Text ELITE to 47121 to sign up now and get our watchlists sent directly to your phone! Or text CLOSE to 47121 to get on the mobile alert list for our Closing Bell Roundup report, featuring the day's top winners and losers. *Standard message/carrier rates may apply. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails. [Bots click here]( 1969 S. ALAFAYA TRAIL Orlando FL 32828 USA [Unsubscribe]( | [Change Subscriber Options](